Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 4/2002

01-05-2002 | Case Report

Failure to Detect Epstein-Barr Virus (EBV) DNA in Plasma by Real-Time PCR in a Case of EBV-Associated Posttransplantation Lymphoproliferative Disorder Confined to the Central Nervous System

Authors: Teruhiko Terasawa, Haruhiko Ohashi, Keitaro Tsushita, Makoto Utsumi, Eiichiro Mukai, Shigeo Nakamura, Masanori Shimoyama

Published in: International Journal of Hematology | Issue 4/2002

Login to get access
Metadata
Title
Failure to Detect Epstein-Barr Virus (EBV) DNA in Plasma by Real-Time PCR in a Case of EBV-Associated Posttransplantation Lymphoproliferative Disorder Confined to the Central Nervous System
Authors
Teruhiko Terasawa
Haruhiko Ohashi
Keitaro Tsushita
Makoto Utsumi
Eiichiro Mukai
Shigeo Nakamura
Masanori Shimoyama
Publication date
01-05-2002
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2002
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/BF02982135

Other articles of this Issue 4/2002

International Journal of Hematology 4/2002 Go to the issue

OriginalPaper

Mast Cells Derived from Embryonic Stem Cells: A Model System for Studying the Effects of Genetic Manipulations on Mast Cell Development, Phenotype, and Function In Vitro and In Vivo

Letter to the Editor

Acute Lymphoblastic Leukemia with t(1;9;22)(q32;q34;Q11)

Case Report

Sodium Salicylate—Triggered Apoptosis in HL-60 Cells Depends on Caspase-8 Activation

Case Report

Epstein-Barr Virus-Associated B-Cell Type Non-Hodgkin’s Lymphoma with Concurrent p53 Protein Expression in a Rheumatoid Arthritis Patient Treated with Methotrexate

Review Article

Human CD34− Hematopoietic Stem Cells: Basic Features and Clinical Relevance

Case Report

Diagnostic Significance of Measurement of the Receptor for Urokinase-Type Plasminogen Activato on Granulocytes and in Plasma from Patients with Paroxysmal Nocturnal Hemoglobinuria
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits